Additionally, our finding of increased 5hmC in RAP1B, a GTP-binding protein associated with poor prognosis in multiple cancers, including lung cancer [54], indicates potential new directions for therapy, including the use of hypomethylating agents. Here, RAP1B is linked to lung cancer.